Intelligence · Clinical pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
Pipeline programs
-
Cymbalta hard gastro-resistant capsules for chemotherapy-induced neuropathi…
Disc Medicine
chemotherapy-induced neuropathic pain
1 trial -
Cytokine-induced killer cells+ FOLFOX4
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
D-CURE 25000 UI gélules., Placebo of vitamin D
Laboratoire HRA Pharma
Periodontitis
1 trial -
D3250C00059
AstraZeneca AB
Severe eosinophilic asthma
1 trial -
D5980C00048
AstraZeneca AB
Chronic Obstructive Pulmonary Disease
1 trial -
D8223C00016
AstraZeneca AB
Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
1 trial -
D9311L00001
AstraZeneca
Advanced or recurrent endometrial cancer
1 trial -
DAN-COVID
Moderna Biotech Spain
SARS-CoV-2 infection
1 trial -
DAN-RSV
Pfizer Australia Pty Ltd
RSV-infection
1 trial -
DAN-ZOSTER
GlaxoSmithKline
Herpes Zoster
1 trial -
DARBEPOETIN ALFA
The George Institute
hepatic trasplant
1 trial -
DIGOXIN
Disc Medicine
heart failure
1 trial -
DISCARD
Verona Pharma Ireland Limited
Patients with currently remitted depressive disorders.
1 trial -
DOAC
Rhythm Pharmaceuticals Netherlands B.V.
Ventricular Tachycardia
1 trial -
DOBUTAMINE , LEVOSIMENDAN
The George Institute
Heart failure patients with depressed left ventricular ejection fraction
1 trial -
DON3
Fondazione Telethon ETS
obese elderly people with vitamin D deficiency
1 trial -
DONEPEZIL, DONEPEZIL
Pari Pharma GmbH
Interest of adding donepezil to the non-medicinal care pathway recommended in France for Alzheimer's disease
1 trial -
DORALI
MEDA Pharma GmbH & Co. KG
Human Immunodeficiency Virus
1 trial -
DOTAREM for Breast Cancer
Disc Medicine
Breast Cancer
1 trial -
DR200090
Tour Hekla
Labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening
1 trial -
DR230314
Tour Hekla
Evaluation of the CKD-Epi score to identify a glomerular filtration threshold predictive of morphine failure at usual dosage, using a reference method for assessing renal function: iohexol clearance. All other aspects of the protocol are part of standard care practice.
1 trial -
DR240305
Tour Hekla
Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by disabling symptoms of inattention and/or hyperactivity-impulsivity beginning before the age of 12 with significant personal, social, academic and/or occupational impact (American Psychiatric Association 2013). This disorder, whose prevalence is around 5% in children and adolescents, affects 2.6% of adults (American Psychiatric Association 2013; Song et al. 2021).
1 trial -
DS-8201a
AstraZeneca AB
Treatment of patients with HER2-positive breast cancer with or without brain metastasis
1 trial -
Dabigatran Etexilate
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Danhong injection
BRIGHT MINDS BIOSCIENCES INC.
Unstable Angina Pectoris
1 trial -
Danhong injection
BRIGHT MINDS BIOSCIENCES INC.
Acute Stroke
1 trial -
Danlou Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease(CAD)
1 trial -
Dapagliflozin
AstraZeneca
Diabetes Mellitus, Type 2
1 trial -
Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy
The University of Hong Kong
Fontan
1 trial -
Dapagliflozin 10 MG
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Daphnetin
The First People's Hospital of Lianyungang
Lower Extremity Lymphedema
1 trial -
Daratumumab and corticosteroid treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Hemophilia
1 trial -
Darvadstrocel
Takeda
Crohn's Disease
3 trials -
De-escalated Dual Antiplatelet Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
De-escalation strategy
Dong Wang
Acute Myocardial Infarction
1 trial -
DePuy ASR Hip System
International Peace Maternity and Child Health Hospital
Rheumatoid Arthritis
1 trial -
Dengzhan Shengmai capsule
Universal Integrated
Stroke
1 trial -
Dental foam "Biorepair PERIBIOMA"
The First People's Hospital of Lianyungang
Oral Health
1 trial -
Depo-Medroxyprogesterone Acetate
United Therapeutics Europe Ltd
HIV
1 trial -
Depofoam bupivacaine
Pacira Ireland Limited
Pain, Postoperative
1 trial -
Desipramine
BRIGHT MINDS BIOSCIENCES INC.
Substance-Related Disorders
1 trial -
Desmopressin
The First People's Hospital of Lianyungang
Patients Undergoing Endoscopic Sinus Surgery
1 trial -
Desvenlafaxine Succinate
Grace Therapeutics
Vascular Depression
1 trial -
Deutetrabenazine
Teva Pharma GmbH
Huntington's Disease
1 trial -
Deutetrabenazine Oral Capsule
Teva Pharma GmbH
Tardive Dyskinesia
1 trial -
Dex-Esk
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.